IDEX Corporation Declares Regular Quarterly Cash Dividend
Circulating Tumor Cells Patent Landscape and Forecast 2024-2032 - The U.S. Leads with Over 4,000 Patent Filings, Driven by Robust R&D Infrastructure and Substantial Investments in Cancer Diagnostics [Yahoo! Finance]
Auburn University researchers hard at work pioneering energy-related advancements of future [Yahoo! Finance]
Here's Why SouthernSun SMID Cap Investment Strategy Exited IDEX Corporation (IEX) [Yahoo! Finance]
IDEX Co. (NYSE: IEX) had its price target raised by analysts at Royal Bank of Canada from $236.00 to $248.00. They now have an "outperform" rating on the stock.